Daniel A. Dumesic

other 2020

Midgestation origins of androgenic and estrogenic pathophysiology in three major women's health disorders

Fertility and sterility ·doi:10.1016/j.fertnstert.2020.08.024

2017

Use of fertility medications and cancer risk: a review and update.

Current opinion in obstetrics & gynecology ·doi:10.1097/gco.0000000000000370

Purpose of reviewThere is increasing use of fertility medications for ovulation induction and ovarian stimulation for in-vitro fertilization in the treatment of female infertility. In this review, recent literature regarding the association…

review 2015

Inflammatory Factors in Reproductive Medicine

·doi:10.1055/s-0035-1556723

As Guest Editor for this edition of Seminars in Reproductive Medicine, I welcome you to this exciting selection of papers regarding inflammatory factors in reproductive medicine. As a biological process governing complex immunological actio…

2015

Intrafollicular cortisol levels inversely correlate with cumulus cell lipid content as a possible energy source during oocyte meiotic resumption in women undergoing ovarian stimulation for in vitro fertilization.

Fertility and sterility ·doi:10.1016/j.fertnstert.2014.09.034

ObjectiveTo determine whether follicular fluid (FF) cortisol levels affect cumulus cell (CC) lipid content during oocyte meiotic resumption, and whether CCs express genes for glucocorticoid action.DesignProspective cohort study.SettingAcade…

2014

21-Hydroxylase-derived steroids in follicles of nonobese women undergoing ovarian stimulation for in vitro fertilization (IVF) positively correlate with lipid content of luteinized granulosa cells (LGCs) as a source of cholesterol for steroid synthesis.

The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2013-3204

ContextMineralocorticoid synthesis by the nonhuman primate periovulatory follicle enhances luteinization. Whether a similar event occurs in women undergoing in vitro fertilization (IVF) is unknown.ObjectiveThe objective of the study was to …

2013

A novel approach to quantifying ovarian cell lipid content and lipid accumulation in vitro by confocal microscopy in lean women undergoing ovarian stimulation for in vitro fertilization (IVF).

Journal of assisted reproduction and genetics ·doi:10.1007/s10815-013-9976-2

PurposeTo quantify intracellular lipid levels in cumulus cells (CCs) and mural granulosa cells (MGCs) of lean women undergoing gonadotropin therapy for in vitro fertilization (IVF), based upon different cell preparation methods.MethodsCCs a…

2009

Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer.

Fertility and sterility ·doi:10.1016/j.fertnstert.2008.04.047

ObjectiveTo investigate the relationship between antimüllerian hormone (AMH) and steroidogenesis in follicles of normoandrogenic ovulatory women undergoing follicle-stimulating hormone (FSH) therapy for in vitro fertilization/embryo transfe…

article 2001

Retroperitoneal endometriosis causing unilateral hip pain

Obstetrics and gynecology ·doi:10.1016/s0029-7844(01)01329-1

BACKGROUND: The usual symptoms of endometriosis are secondary dysmenorrhea, dyspareunia, and infertility, but when located in the retroperitoneal space, it might have atypical symptoms that delay diagnosis and postpone therapy. CASE: A youn…

article 2001

Retroperitoneal Endometriosis Causing Unilateral Hip Pain

·doi:10.1097/00006250-200111001-00034

In Brief BACKGROUND The usual symptoms of endometriosis are secondary dysmenorrhea, dyspareunia, and infertility, but when located in the retroperitoneal space, it might have atypical symptoms that delay diagnosis and postpone therapy. CASE…

article 1995

Endometriosis: Advanced Management and Surgical Techniques

Mayo Clinic proceedings ·doi:10.4065/70.9.918-b

article 1995

Endometriosis: Advanced Management and Surgical Techniques

·doi:10.1016/s0025-6196(11)63954-2

review 1987

Therapeutic uses of gonadotropin-releasing hormone analogs

Obstetrical & gynecological survey ·doi:10.1097/00006254-198701000-00001

Since the discovery and synthesis of gonadotropin-releasing hormone (GnRH) in 1971, numerous long-acting agonistic and antagonistic analogs have been synthesized. Agonistic analogs were found to desensitize pituitary GnRH receptors with chr…